Literature DB >> 27113793

Ocular Lyme borreliosis as a rare presentation of unilateral vision loss.

Jeffrey Patterson-Fortin1, Anita Kohli2, Maria J Suarez3, P Elliott Miller1.   

Abstract

Ocular Lyme borreliosis is a rare manifestation of Lyme disease. We describe a case of an 80-year-old woman who presented with a 1-month history of unilateral painless central vision loss. Based on a temporal artery biopsy, she was initially diagnosed with giant cell arteritis and treated with a 3-day course of high-dose intravenous steroids. A more detailed history uncovered multiple previous treatments for Lyme disease and residence in an endemic Lyme area. The patient was subsequently diagnosed with ocular Lyme borreliosis and treated with intravenous antibiotics. After 5 weeks of treatment, unilateral vision loss did not progress and optic disc oedema resolved. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27113793      PMCID: PMC4854126          DOI: 10.1136/bcr-2016-215307

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Three cases of neuroborreliosis misdiagnosed as giant cell arteritis.

Authors:  F Träisk; M Andersson; E Svenungsson
Journal:  Scand J Rheumatol       Date:  2012-03       Impact factor: 3.641

2.  Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Authors:  Mehrdad Mazlumzadeh; Gene G Hunder; Kirk A Easley; Kenneth T Calamia; Eric L Matteson; W Leroy Griffing; Brian R Younge; Cornelia M Weyand; Jörg J Goronzy
Journal:  Arthritis Rheum       Date:  2006-10

3.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

4.  Reactive Lyme serology in optic neuritis.

Authors:  Patrick Sibony; John Halperin; P K Coyle; Kartik Patel
Journal:  J Neuroophthalmol       Date:  2005-06       Impact factor: 3.042

Review 5.  Reinfection in patients with Lyme disease.

Authors:  Robert B Nadelman; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2007-09-11       Impact factor: 9.079

6.  The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.

Authors:  R B Nadelman; J Nowakowski; G Forseter; N S Goldberg; S Bittker; D Cooper; M Aguero-Rosenfeld; G P Wormser
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

7.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.

Authors:  A Mygland; U Ljøstad; V Fingerle; T Rupprecht; E Schmutzhard; I Steiner
Journal:  Eur J Neurol       Date:  2009-11-23       Impact factor: 6.089

8.  Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

Authors:  A C Steere; S E Malawista; D R Snydman; R E Shope; W A Andiman; M R Ross; F M Steele
Journal:  Arthritis Rheum       Date:  1977 Jan-Feb

Review 9.  Optic nerve involvement in Lyme disease.

Authors:  Frank Träisk; Lars Lindquist
Journal:  Curr Opin Ophthalmol       Date:  2012-11       Impact factor: 3.761

10.  The expanding clinical spectrum of ocular lyme borreliosis.

Authors:  H O Mikkilä; I J Seppälä; M K Viljanen; M P Peltomaa; A Karma
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

  10 in total
  1 in total

1.  Contrast Sensitivity Loss in Patients With Posttreatment Lyme Disease.

Authors:  Alison W Rebman; Ting Yang; John N Aucott; Erica A Mihm; Sheila K West
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.